Release
📈 Stocks
HERVolution Validates IPT-001 Pipeline With HERV-K Expression Data
(just now)
HERVolution shares gain momentum as new clinical data confirms HERV-K expression in 43 cancer types, validating the therapeutic potential of the company's…